BeOne Medicines Ltd. (HKG:6160)
191.50
+6.50 (3.51%)
Aug 15, 2025, 4:08 PM HKT
BeOne Medicines Employees
BeOne Medicines had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
3.26M HKD
Profits / Employee
-126.77K HKD
Market Cap
276.65B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
Innovent Biologics | 5,659 |
Akeso | 3,035 |
Sino Biopharmaceutical | 24,379 |
WuXi Biologics | 12,575 |
CSPC Pharmaceutical Group | 21,400 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
BeOne Medicines News
- 8 days ago - A Glimpse of BeiGene's Earnings Potential - Benzinga
- 10 days ago - BeiGene's Earnings: A Preview - Benzinga
- 10 days ago - BeiGene Q2 2025 Earnings Preview - Seeking Alpha
- 7 weeks ago - Glenmark Pharmaceuticals launches TEVIMBRA in India for advanced lung and esophageal cancer treatment - Business Upturn
- 2 months ago - Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval - Business Upturn
- 2 months ago - Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple - Investor's Business Daily
- 2 months ago - BeiGene gets EU backing for neck and head cancer treatment - Seeking Alpha
- 3 months ago - Market Shrugs Off This Drugmaker's Turnaround - Benzinga